Journal Logo

Poster Session II: Chronic myeloid leukemia – Clinical

PS1177 PROGNOSTIC FACTORS FOR MOLECULAR RELAPSE-FREE SURVIVAL AFTER DISCONTINUATION OF TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA BASED ON RUSSIAN MULTICENTER PROSPECTIVE TRIAL (RU-SKI)

Shukhov, O.1; Chelysheva, E.1; Petrova, A.1; Bykova, A.1; Nemchenko, I.1; Turkina, A.1

Author Information
doi: 10.1097/01.HS9.0000562992.29771.be
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.